Skip to main content

Peer Review reports

From: Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis

Original Submission
19 Feb 2015 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
Resubmission - Version 8
Submitted Manuscript version 8
Resubmission - Version 9
Submitted Manuscript version 9
Resubmission - Version 10
Submitted Manuscript version 10
Reviewed Reviewer Report
Resubmission - Version 11
Submitted Manuscript version 11
Publishing
18 Sep 2015 Editorially accepted
29 Sep 2015 Article published 10.1186/s12872-015-0100-7

You can find further information about peer review here.

Back to article page